Mach7 Technologies Ltd (ASX: M7T) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Mach7 Technologies Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $121.80 million
P/E Ratio 1,428.57
Dividend Yield N/A
Shares Outstanding 238.83 million
Earnings per share -0.011
Dividend per share N/A
Year To Date Return -37.80%
Earnings Yield 0.07%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Mach7 Technologies Ltd (ASX: M7T)
Latest News

ASX shares soaring higher
Share Gainers

Why Adairs, Fisher & Paykel Healthcare, Mach7, & WiseTech are pushing higher

Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) and WiseTech Global Ltd (ASX:WTC) shares are two of four ending the week…

Read more »

man riding bull on an upward trending arrow
Share Gainers

Why this small cap ASX tech share is rocketing 15% higher today

The Mach7 Technologies Ltd (ASX:M7T) share price is rocketing higher on Friday after delivering very strong first half profit growth...

Read more »

technology graphic
Share Market News

Here’s why analysts are bullish on this ASX tech stock

Here’s why analysts from financial services firm Taylor Collison think this ASX tech stock is poised to rocket in 2020…

Read more »

growth shares
Share Gainers

Life360 share price rises 7% on strong quarterly update

Shares in Life360 Inc (ASX: 360) are up in Wednesday trade following the release of the company's quarterly business update…

Read more »

graphic image of cloud computed and data storage
⏸️ Investing

Mach7 share price jumps on solid quarterly update

The Mach7 Technologies Ltd (ASX: M7T) share price jumped more than 3% in early trade after the company released its…

Read more »

Financial Technology
Capital Raising

Why Mach7 Technologies is in a trading halt

Mach7 Technologies Ltd (ASX: M7T) requests a trading halt pending a material announcement regarding a proposed capital raising.

Read more »

ASX shares higher
Share Gainers

Mach7 Technologies share price jumps 15% on quarterly update

The Mach7 Technologies share price is climbing higher in Thursday trade following the release of a bullish quarterly update.

Read more »

Man pressing digital button in a futuristic touchscreen monitor
Share Market News

Results: Mach7 share price wobbles after loss balloons by 40%

The Mach7 Technologies Ltd (ASX: M7T) reported a 42% rising loss this morning in its financial year 2019 results.

Read more »

M7T ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Mach7 Technologies Ltd

Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.

M7T Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
01 Jul 2022 $0.51 $0.02 4.08% 76,088 $0.51 $0.57 $0.51
30 Jun 2022 $0.49 $0.00 0.00% 475,991 $0.49 $0.50 $0.48
29 Jun 2022 $0.49 $-0.02 -3.92% 458,709 $0.52 $0.52 $0.45
28 Jun 2022 $0.51 $-0.05 -8.93% 173,070 $0.55 $0.55 $0.50
27 Jun 2022 $0.56 $0.06 12.00% 402,849 $0.51 $0.56 $0.51
24 Jun 2022 $0.50 $0.05 11.11% 330,758 $0.45 $0.51 $0.45
23 Jun 2022 $0.45 $-0.03 -6.25% 302,976 $0.49 $0.49 $0.45
22 Jun 2022 $0.48 $-0.02 -4.00% 253,337 $0.51 $0.51 $0.48
21 Jun 2022 $0.50 $0.02 4.12% 129,870 $0.51 $0.51 $0.48
20 Jun 2022 $0.49 $-0.02 -3.96% 236,279 $0.50 $0.50 $0.47
17 Jun 2022 $0.51 $-0.03 -5.61% 101,140 $0.51 $0.52 $0.49
16 Jun 2022 $0.54 $-0.02 -3.64% 277,186 $0.56 $0.56 $0.50
15 Jun 2022 $0.55 $-0.03 -5.17% 115,258 $0.58 $0.58 $0.55
14 Jun 2022 $0.58 $-0.03 -4.92% 158,621 $0.58 $0.58 $0.54
10 Jun 2022 $0.61 $-0.01 -1.63% 128,778 $0.63 $0.66 $0.60
09 Jun 2022 $0.62 $-0.03 -4.69% 304,474 $0.64 $0.64 $0.61
08 Jun 2022 $0.64 $0.00 0.00% 74,910 $0.62 $0.64 $0.62
07 Jun 2022 $0.64 $0.00 0.00% 168,204 $0.62 $0.64 $0.60
06 Jun 2022 $0.64 $0.05 8.40% 590,597 $0.61 $0.64 $0.60
03 Jun 2022 $0.60 $-0.01 -1.67% 186,557 $0.61 $0.63 $0.60

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
31 May 2022 David Chambers Buy 12 $7,835
On-market trade.
24 May 2022 David Chambers Buy 6 $3,685
On-market trade.
12 May 2022 Robert Bazzani Buy 43 $24,966
On-market trade.
11 Nov 2021 Philippe Houssiau Issued 250 $233,750
Issue of options.
11 Nov 2021 David Chambers Issued 35 $32,725
Issue of options.
11 Nov 2021 Eliot Siegel Issued 25 $23,375
Issue of options.
11 Nov 2021 Mike Lampron Issued 402 $376,042
Issue of securities. 780,299 - Performance Rights
11 Nov 2021 Robert Bazzani Issued 25 $23,375
Issue of options.
29 Sep 2021 David Chambers Buy 21 $20,895
On-market trade. Average price
As per announcement on 30/09/2021

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr David Chambers Non-Executive DirectorNon-Executive Chairman Aug 2018
Mr Chambers has more than 30 years experience in the Healthcare and Life Science industry and a track record in healthcare IT systems through a series of senior executive roles in Australia, North America, Europe, and Asia. David up until recently acted as Managing Director, Asia-Pacific, of Allscripts Healthcare Solutions, a NASDAQ listed billion-dollar global leader in Healthcare Technology, retiring after close to seven years, on 30th June 2020. Prior to that David was General Manager, Asia and ANZ with Carestream Health. He was former chief executive of ASX-Listed health software business Pro Medicus Limited. David also served eleven years with Agfa Healthcare, including managing their Informatics group in Asia Pacific, and culminating in his elevation to Vice President of Agfa North America.
Dr Eliot L Siegel Non-Executive Director Aug 2018
Dr Siegel is currently Professor and Vice Chair of information systems at the University of Maryland School of Medicine, Department of Diagnostic Radiology, and the Chief of Radiology and Nuclear Medicine for the Veterans Affairs Maryland Healthcare System, both in Baltimore, MD as well as adjunct professor of computer science and biomedical engineering at the undergraduate campuses of the University of Maryland. Under his guidance, the VA Maryland Healthcare System became the first filmless healthcare enterprise in the World. He has written over 300 articles and book chapters about PACS (Picture Archiving and Communication Systems) and digital imaging, and has edited six books on the topic, including Filmless Radiology and Security Issues in the Digital Medical Enterprise. He has given more than 1,000 presentations throughout the world on a broad range of topics involving the use of computers in medicine and artificial intelligence. Dr. Siegel was symposium chairman for the Society of Photo-optical and Industrial Engineers (SPIE) Medical Imaging Meeting for three years and has been honored as a fellow in that organization as well as the American College of Radiology. He is also a Board member of Carestream Health, a billion-dollar global company in digital radiography and computed radiography systems and serves on numerous advisory boards in medical imaging.
Mr Mike Lampron Chief Operating OfficerChief Executive OfficerManaging Director Mar 2019
Mr Lampron have more than 20 years of experience in business and operational management for Healthcare IT companies, Mike brings a experience ranging from private start-up organizations as well as long established companies such as IBM and GE. Mike was previously the Chief Executive Officer for a National Teleradiology Company and has a proven ability to drive results through a combination of astute analysis, innovative execution and cross-functional teamwork.
Mr Robert John Bazzani Non-Executive Director Jan 2020
Mr Bazzani has spent the past 20 years with the global consulting firm KPMG, where he rose to the top and served as Chairman of KPMG Victoria, National Managing Partner for KPMG Australia's Enterprise Division and National Managing Partner for KPMG's M&A Division. Whilst in these roles, Rob was a member of KPMG's National Executive Committee (NEC), which oversees and is responsible for the Firm's turnover, strategic decision making, profitability and operations. Rob has a demonstrated record of leading and growing large scale and complex businesses. He has played a significant role in advising clients (public, private, and global subsidiaries) on commercial maters, public transitions, corporate governance, M&A and has engaged with Government and Regulators. With extensive experience in corporate advisory, Rob has deep commercial and industry knowledge across financial services, asset and wealth management, property, insurances and consumer & industrial markets.
Mr Philippe Houssiau Non-Executive Director Jan 2021
Mr Houssiau held a variety of executive roles as Partner with PriceWaterhouse and PwC, CEO of Agfa Healthcare, where he transitioned the business from being an Analog Film manufacturing outfit to become a world leader in Imaging and Health IT, CEO of Alliance Medical, the leading European Imaging Services Provider and CEO/ Chairman of the Rhapsody Healthcare Interoperability business, now Lyniate. Philippe also ran the CSC/DxC Healthcare business in the UK and Netherlands and held many board and Chair positions, in Imaging and Healthcare. He currently serves as the CEO of MAKSystem, the leading Blood Management Software company and as Chairman of Corilus (Primary Care). Philippe is based in Antwerp, Belgium.
Ms Veronique Morgan-Smith Company Secretary Oct 2021
-
Jenni Pilcher Chief Financial Officer & Company Secretary
-
Steve Rankin Chief Product Officer
-
Veronique Morgan-Smith Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Sandhurst Trustees Ltd 37,232,085 15.74%
J P Morgan Nominees Australia Pty Limited 32,393,265 13.69%
National Nominees Limited 32,166,789 13.60%
Hsbc Custody Nominees (Australia) Limited 9,263,892 3.92%
Ubs Nominees Pty Ltd 4,756,201 2.01%
PT Dwi Satrya Utama 4,392,959 1.86%
Perco Group Pty Ltd 3,980,000 1.68%
Bpnt Pty Ltd 3,897,000 1.65%
Padmalwar Prakash 3,569,921 1.51%
Chew & Partners (Import & Export) Pte Ltd 2,900,074 1.23%
Albert Liong Pak-Fai 2,044,189 0.86%
BNP Paribas Noms Pty Ltd 2,031,228 0.86%
Citicorp Nominees Pty Limited 1,963,367 0.83%
Mr Ravindran Krishnan 1,771,437 0.75%
Ty Webb Pty Ltd 1,339,444 0.57%
HSBC Custody Nominees (Australia) Limited I 1,160,287 0.49%
Moggs Creek Pty Ltd 1,000,000 0.42%
62 Darlinghurst Road Pty Ltd 1,000,000 0.42%
Australian Executor Trustees Limited 996,134 0.42%
Citicorp Nominees Pty Limited I 963,285 0.41%
BNP Paribas Noms Pty Ltd I 878,146 0.37%

Profile

since

Note